Compounds > aspirin

aspirin and nitrosobis(2-oxopropyl)amine

aspirin has been researched along with nitrosobis(2-oxopropyl)amine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Furukawa, F; Hasegawa, R; Hayashi, Y; Imaida, K; Sato, H; Takahashi, M; Toyoda, K1
Gao, J; Iatropoulos, MJ; Kashfi, K; Kopelovich, L; Ouyang, N; Rigas, B; Tsioulias, GJ; Williams, JL1
Grandhi, BK; Prabhu, S; Thakkar, A; Wang, J1

Other Studies

3 other study(ies) available for aspirin and nitrosobis(2-oxopropyl)amine

ArticleYear
Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine.
    Carcinogenesis, 1990, Volume: 11, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinogens; Cricetinae; Female; Indomethacin; Mesocricetus; Nitrosamines; Pancreatic Neoplasms; Pancreatitis; Phenylbutazone

1990
Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model.
    Cancer research, 2006, Apr-15, Volume: 66, Issue:8

    Topics: Animals; Anticarcinogenic Agents; Apoptosis; Aspirin; Carcinogens; Cell Growth Processes; Cricetinae; Cyclin-Dependent Kinase Inhibitor p21; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Female; Mesocricetus; NF-kappa B; Nitric Oxide Donors; Nitrosamines; Pancreas; Pancreatic Neoplasms

2006
A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions.
    Cancer prevention research (Philadelphia, Pa.), 2013, Volume: 6, Issue:10

    Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aspirin; Carcinogens; Cell Line, Tumor; Cricetinae; Curcumin; Disease Models, Animal; Disease Progression; Drug Delivery Systems; Immunohistochemistry; In Situ Nick-End Labeling; Isothiocyanates; Lipids; Male; Mesocricetus; Nanoparticles; Nitrosamines; Pancreatic Neoplasms; Proliferating Cell Nuclear Antigen; Sulfoxides

2013